Open life sciences · 2025
Dissecting the molecular mechanisms of T cell infiltration in psoriatic lesions via cell-cell communication and regulatory network analysis.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Li Kexin, Ge Xinhong, Shang Yuanyuan, Jiao Yaning, Dong Lingdi, Yu Yingyao
Аннотация
This study aims to elucidate the intercellular communication mechanisms underlying T cell infiltration in psoriatic skin. Single-cell RNA sequencing revealed increased proportions of endothelial cells and T cells, alongside a reduction in melanocytes in psoriatic skin. Pseudotime analysis demonstrated dynamic transitions in T cell states, with significant gene expression changes at key branching points. These genes were enriched in pathways related to the ribosome, cytoplasmic translation, and ribosomal structural components. Cell-cell communication analysis showed enhanced interactions, particularly between T cells and fibroblasts in psoriasis. Fibroblasts exhibited upregulated MK signaling, characterized by elevated MDK expression and increased MDK receptor levels on T cells, suggesting MDK-mediated T cell recruitment. Regulatory network analysis identified IL-6 as a primary ligand regulating MDK via STAT3 and AHR, with increased expression of IL-6R, STAT3, and AHR in psoriatic fibroblasts. CuE treatment significantly alleviated psoriasis-like symptoms in a mouse model, as evidenced by reduced PASI scores, epidermal hyperplasia, and inflammatory cytokine levels. Mechanistically, CuE inhibited the STAT3/MDK signaling pathway, indicating its role in modulating fibroblast-driven T cell recruitment in psoriatic inflammation. This study demonstrates that CuE alleviates psoriasis-like symptoms by inhibiting the IL-6-STAT3-MDK signaling axis, positioning it as a potential novel therapeutic targeting fibroblast-mediated immune interactions in psoriasis.